TC
AERI

TFS Capital’s Aerie Pharmaceuticals AERI Stock Holding History

TFS Capital’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,708
Closed -$524K – 1137
2015
Q1 		$524K Buy
+16,708
New +$484K 0.05% 534
2014
Q4 		– Sell
-20,207
Closed -$418K – 1197
2014
Q3 		$418K Buy
20,207
+5,581
+38% +$110K 0.04% 651
2014
Q2 		$362K Sell
14,626
-5,229
-26% -$90.6K 0.03% 764
2014
Q1 		$421K Buy
+19,855
New +$401K 0.03% 818

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital's AERI Position: Q2 2015 in Review

TFS Capital sold out of Aerie Pharmaceuticals (AERI) in Q2 2015, closing a stake of 16,708 shares — an estimated $524K sold.

TFS Capital first reported a position in AERI in Q1 2014 and held it in 4 quarters. The position peaked at $524K in Q1 2015. 108 funds tracked by Wall St. Rank hold AERI as of Q2 2015.

  • TFS Capital reported no remaining Aerie Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • TFS Capital sold 16,708 Aerie Pharmaceuticals shares in Q2 2015, an estimated $524K.
  • TFS Capital first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • TFS Capital's Aerie Pharmaceuticals position peaked at $524K in Q1 2015.
  • 108 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2015.

Based on TFS Capital's 13F filing for Q2 2015, filed 5 Aug 2015.